CORT

#1301
Corcept Therapeutics Inc.
35.7000
+3.13%
Sector:
Básica:
Profit Currency:
Rango diario
35.7000
35.7000
Rango anual
28.6601
89.0000
Cambio diario
+3.13%
Monthly Change
-22.83%
6 month change
-51.34%
Cambio anual
-51.34%
Cierres anteriores
34.6150
Open
35.7000
Bid
Ask
Low
35.7000
High
35.7000
Volumen
111
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization 3.7079 B
  • Employee 500
  • Founded 1998
  • CEO N/A
  • Website www.corcept.com
  • Headquarter Delaware, United States
  • FIGI BBG000BKJG33
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
42.44
Price to sales ratio
5.48
Dividends per share
—
Dividend yield %
—

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD.

Noticias